Literature DB >> 23426954

Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.

Jahan Marcu1, Derek M Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H Reggio, Mary E Abood.   

Abstract

Activation of the cannabinoid CB1 receptor (CB1) is modulated by aspartate residue D2.63(176) in transmembrane helix (TMH) 2. Interestingly, D2.63 does not affect the affinity for ligand binding at the CB1 receptor. Studies in class A G protein-coupled receptors have suggested an ionic interaction between residues of TMH2 and 7. In this report, modeling studies identified residue K373 in the extracellular-3 (EC-3) loop in charged interactions with D2.63. We investigated this possibility by performing reciprocal mutations and biochemical studies. D2.63(176)A, K373A, D2.63(176)A-K373A, and the reciprocal mutant with the interacting residues juxtaposed D2.63(176)K-K373D were characterized using radioligand binding and guanosine 5'-3-O-(thio)triphosphate functional assays. None of the mutations resulted in a significant change in the binding affinity of N-(piperidiny-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride (SR141716A) or (-)-3cis -[2-hydroxyl-4-(1,1-dimethyl-heptyl)phenyl]-trans-4-[3-hydroxyl-propyl] cyclohexan-1-ol (CP55,940). Modeling studies indicated that binding-site interactions and energies of interaction for CP55,940 were similar between wild-type and mutant receptors. However, the signaling of CP55,940, and (R)-(+)-[2,3-dihydro-5-methyl-3-[(4-morpholinyl)methyl]-pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl](1-naphthalenyl)-methanone mesylate (WIN55,212-2) was impaired at the D2.63(176)A-K373A and the single-alanine mutants. In contrast, the reciprocal D2.63(176)K-K373D mutant regained function for both CP55,940 and WIN55,212-2. Computational results indicate that the D2.63(176)-K373 ionic interaction strongly influences the conformation(s) of the EC-3 loop, providing a structure-based rationale for the importance of the EC-3 loop to signal transduction in CB1. The putative ionic interaction results in the EC-3 loop pulling over the top (extracellular side) of the receptor; this EC-3 loop conformation may serve protective and mechanistic roles. These results suggest that the ionic interaction between D2.63(176) and K373 is important for CB1 signal transduction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426954      PMCID: PMC3629795          DOI: 10.1124/jpet.112.201046

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  35 in total

Review 1.  Ligand based structural studies of the CB1 cannabinoid receptor.

Authors:  R P Picone; D J Fournier; A Makriyannis
Journal:  J Pept Res       Date:  2002-12

2.  Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation.

Authors:  Marco Scarselli; Bo Li; Soo-Kyung Kim; Jürgen Wess
Journal:  J Biol Chem       Date:  2007-01-09       Impact factor: 5.157

3.  Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified.

Authors:  Matthew Conner; Stuart R Hawtin; John Simms; Denise Wootten; Zoe Lawson; Alex C Conner; Rosemary A Parslow; Mark Wheatley
Journal:  J Biol Chem       Date:  2007-04-02       Impact factor: 5.157

4.  The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones.

Authors:  Alex Straiker; Jim Wager-Miller; Ken Mackie
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Cysteine residues in the human cannabinoid receptor: only C257 and C264 are required for a functional receptor, and steric bulk at C386 impairs antagonist SR141716A binding.

Authors:  Jonathan F Fay; Thomas D Dunham; David L Farrens
Journal:  Biochemistry       Date:  2005-06-21       Impact factor: 3.162

Review 6.  An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity.

Authors:  F D Christopoulou; D N Kiortsis
Journal:  J Clin Pharm Ther       Date:  2011-02       Impact factor: 2.512

7.  Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.

Authors:  W Jin; S Brown; J P Roche; C Hsieh; J P Celver; A Kovoor; C Chavkin; K Mackie
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

8.  Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit.

Authors:  H E Hamm; D Deretic; A Arendt; P A Hargrave; B Koenig; K P Hofmann
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

9.  Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization.

Authors:  Kwang H Ahn; Alexander C Bertalovitz; Dale F Mierke; Debra A Kendall
Journal:  Mol Pharmacol       Date:  2009-07-30       Impact factor: 4.436

10.  An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region.

Authors:  Sean D McAllister; Gulrukh Rizvi; Sharon Anavi-Goffer; Dow P Hurst; Judy Barnett-Norris; Diane L Lynch; Patricia H Reggio; Mary E Abood
Journal:  J Med Chem       Date:  2003-11-20       Impact factor: 7.446

View more
  10 in total

1.  Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.

Authors:  Robert B Laprairie; Abhijit R Kulkarni; Pushkar M Kulkarni; Dow P Hurst; Diane Lynch; Patricia H Reggio; David R Janero; Roger G Pertwee; Lesley A Stevenson; Melanie E M Kelly; Eileen M Denovan-Wright; Ganesh A Thakur
Journal:  ACS Chem Neurosci       Date:  2016-04-25       Impact factor: 4.418

2.  Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.

Authors:  Mylyne Tham; Orhan Yilmaz; Mariam Alaverdashvili; Melanie E M Kelly; Eileen M Denovan-Wright; Robert B Laprairie
Journal:  Br J Pharmacol       Date:  2018-08-10       Impact factor: 8.739

3.  Identification of CB1 Receptor Allosteric Sites Using Force-Biased MMC Simulated Annealing and Validation by Structure-Activity Relationship Studies.

Authors:  Dow P Hurst; Sumanta Garai; Pushkar M Kulkarni; Peter C Schaffer; Patricia H Reggio; Ganesh A Thakur
Journal:  ACS Med Chem Lett       Date:  2019-07-10       Impact factor: 4.345

4.  (4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs.

Authors:  Mariam M Mahmoud; Teresa Olszewska; Hui Liu; Derek M Shore; Dow P Hurst; Patricia H Reggio; Dai Lu; Debra A Kendall
Journal:  Mol Pharmacol       Date:  2014-11-19       Impact factor: 4.436

5.  Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.

Authors:  Derek M Shore; Gemma L Baillie; Dow H Hurst; Frank Navas; Herbert H Seltzman; Jahan P Marcu; Mary E Abood; Ruth A Ross; Patricia H Reggio
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

Review 6.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

7.  Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols.

Authors:  Spyros P Nikas; Rishi Sharma; Carol A Paronis; Shashank Kulkarni; Ganesh A Thakur; Dow Hurst; JodiAnne T Wood; Roger S Gifford; Girija Rajarshi; Yingpeng Liu; Jimit Girish Raghav; Jason Jianxin Guo; Torbjörn U C Järbe; Patricia H Reggio; Jack Bergman; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2014-12-16       Impact factor: 7.446

Review 8.  Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities.

Authors:  Szymon Hryhorowicz; Marta Kaczmarek-Ryś; Angelika Andrzejewska; Klaudia Staszak; Magdalena Hryhorowicz; Aleksandra Korcz; Ryszard Słomski
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

9.  The F238L Point Mutation in the Cannabinoid Type 1 Receptor Enhances Basal Endocytosis via Lipid Rafts.

Authors:  Melanie Wickert; Keri L Hildick; Gemma L Baillie; Ruth Jelinek; Alejandro Aparisi Rey; Krisztina Monory; Miriam Schneider; Ruth A Ross; Jeremy M Henley; Beat Lutz
Journal:  Front Mol Neurosci       Date:  2018-07-05       Impact factor: 5.639

10.  GPR6 Structural Insights: Homology Model Construction and Docking Studies.

Authors:  Israa H Isawi; Paula Morales; Noori Sotudeh; Dow P Hurst; Diane L Lynch; Patricia H Reggio
Journal:  Molecules       Date:  2020-02-07       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.